137 related articles for article (PubMed ID: 23467757)
21. Etidronate therapy decreases the sensitivity of bone scanning with methylene diphosphonate labelled with technetium-99m.
Murphy KJ; Line BR; Malfetano J
Can Assoc Radiol J; 1997 Jun; 48(3):199-202. PubMed ID: 9193420
[TBL] [Abstract][Full Text] [Related]
22. Metastasis of femoral osteosarcoma to the abdominal wall detected on 99m Tc-MDP skeletal scintigraphy.
Pirayesh E; Rakhshan A; Amoui M; Rakhsha A; Poor AS; Assadi M
Ann Nucl Med; 2013 Jun; 27(5):478-80. PubMed ID: 23456178
[TBL] [Abstract][Full Text] [Related]
23. Subacute and chronic bone infections: diagnosis using In-111, Ga-67 and Tc-99m MDP bone scintigraphy, and radiography.
Al-Sheikh W; Sfakianakis GN; Mnaymneh W; Hourani M; Heal A; Duncan RC; Burnett A; Ashkar FS; Serafini AN
Radiology; 1985 May; 155(2):501-6. PubMed ID: 3157204
[TBL] [Abstract][Full Text] [Related]
24. Influence of low grade exercise on skeletal scintigraphy using Tc-99m methylene diphosphonate.
Amin A; El-Kareem MA; Yahia AB
Nucl Med Rev Cent East Eur; 2015; 18(2):61-4. PubMed ID: 26315864
[TBL] [Abstract][Full Text] [Related]
25. Scintigraphic evaluation of calcinosis in juvenile dermatomyositis with Tc-99m MDP.
Bar-Sever Z; Mukamel M; Harel L; Hardoff R
Clin Nucl Med; 2000 Dec; 25(12):1013-6. PubMed ID: 11129136
[TBL] [Abstract][Full Text] [Related]
26. Three phase bone scintigraphy with (99m)Tc-MDP and serological indices in detecting infection after internal fixation in malunion or nonunion traumatic fractures.
Yang F; Yang Z; Feng J; Zhang L; Ma D; Yang J
Hell J Nucl Med; 2016; 19(2):130-4. PubMed ID: 27331206
[TBL] [Abstract][Full Text] [Related]
27. Tc-99m MDP and indium-111 chloride scintigraphy in skeletal tuberculosis.
Nocera RM; Sayle B; Rogers C; Wilkey D
Clin Nucl Med; 1983 Sep; 8(9):418-20. PubMed ID: 6227442
[TBL] [Abstract][Full Text] [Related]
28. [24-hour whole-body retention of 99mTc-methylene diphosphonate as an indicator of metabolic activity in osseous tissue in osteopathies].
Kapitola J; Jahoda I; Kobos L; Vilimovská D
Cas Lek Cesk; 1986 Jun; 125(26):815-6. PubMed ID: 3087622
[No Abstract] [Full Text] [Related]
29. [Appraisal of the clinical value of bone scintigraphy for benign bone tumors and tumor-like lesions].
Sato Y; Nakayama C; Kimoto T; Nakata H; Suzuki K
Rinsho Hoshasen; 1987 Jul; 32(7):791-6. PubMed ID: 3682219
[No Abstract] [Full Text] [Related]
30. The role of dual-phase Tc-99m MIBI in the evaluation of potentially operable lesions detected by bone scanning in fibrous dysplasia: a long-term prospective follow-up study.
Ones T; Erol B; Aras M; Dede F; Erdil TY; Inanir S; Turoglu HT
Nucl Med Commun; 2012 Mar; 33(3):288-96. PubMed ID: 22198723
[TBL] [Abstract][Full Text] [Related]
31. Bilateral symmetrical Ollier disease and Tc-99m MDP bone scintigraphy.
Kaya H; Komek H; Cerci SS; Tuzcu SA
Clin Nucl Med; 2004 Jul; 29(7):456. PubMed ID: 15192478
[No Abstract] [Full Text] [Related]
32. SPECT-CT for characterization of extraosseous uptake of 99mTc-methylene diphosphonate on bone scintigraphy.
Soundararajan R; Naswa N; Sharma P; Karunanithi S; Nazar AH; Das KJ; Bal C; Malhotra A; Kumar R
Diagn Interv Radiol; 2013; 19(5):405-10. PubMed ID: 23748034
[TBL] [Abstract][Full Text] [Related]
33. Idiopathic hepatic uptake of (99m)Tc methylene diphosphonate: a case report.
MacDonald J
J Nucl Med Technol; 2001 Mar; 29(1):32-6. PubMed ID: 11283215
[TBL] [Abstract][Full Text] [Related]
34. Utility of delayed whole-body bone scintigraphy after directed three-phase scintigraphy.
Davenport MS; Brown RK; Frey KA
AJR Am J Roentgenol; 2009 Aug; 193(2):338-42. PubMed ID: 19620429
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Tc-99m methylene diphosphonate, Tc-99m human immune globulin, and Tc-99m-labeled white blood cell scintigraphy in the diabetic foot.
Unal SN; Birinci H; Baktiroğlu S; Cantez S
Clin Nucl Med; 2001 Dec; 26(12):1016-21. PubMed ID: 11711704
[TBL] [Abstract][Full Text] [Related]
36. (99m)Tc-MDP scintigraphic findings in children with leukemia: value of early and delayed whole-body imaging.
Shalaby-Rana E; Majd M
J Nucl Med; 2001 Jun; 42(6):878-83. PubMed ID: 11390551
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Tc-99m HIG and three-phase Tc-99m MDP bone scintigraphy for evaluating the efficacy of Yttrium-90 silicate radionuclide synovectomy.
Arzu Gencoglu E; Aras G; Kucuk O; Atay G; Tutak I; Ataman S; Soylu A; Ibis E
Clin Nucl Med; 2003 Apr; 28(4):277-85. PubMed ID: 12642704
[TBL] [Abstract][Full Text] [Related]
38. Brucellosis simulating metastases on Tc-99m MDP bone scan.
Elgazzar AH; Abdel-Dayem HM; Shible O
Clin Nucl Med; 1991 Mar; 16(3):189-91. PubMed ID: 2032437
[No Abstract] [Full Text] [Related]
39. Comparison of whole-body MRI and bone scintigraphy in the detection of bone metastases in renal cancer.
Sohaib SA; Cook G; Allen SD; Hughes M; Eisen T; Gore M
Br J Radiol; 2009 Aug; 82(980):632-9. PubMed ID: 19221182
[TBL] [Abstract][Full Text] [Related]
40. Technetium-99m MDP bone scintigraphy shows multiple abnormalities in sickle cell disease.
Adams BK; Parkar S; Al-Haider ZY
Arch Dis Child; 2003 Jul; 88(7):631. PubMed ID: 12818915
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
